{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:20:43Z","timestamp":1785511243514,"version":"3.56.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T00:00:00Z","timestamp":1592092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973177"],"award-info":[{"award-number":["81973177"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703326"],"award-info":[{"award-number":["81703326"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773580"],"award-info":[{"award-number":["81773580"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802130"],"award-info":[{"award-number":["81802130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2018M630840"],"award-info":[{"award-number":["2018M630840"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019T120641"],"award-info":[{"award-number":["2019T120641"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011360","name":"State Key Laboratory of Natural Medicines","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.apsb.2020.06.007","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T09:31:30Z","timestamp":1592645490000},"page":"621-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Natural products as LSD1 inhibitors for cancer therapy"],"prefix":"10.1016","volume":"11","author":[{"given":"Yuan","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchun","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7207-643X","authenticated-orcid":false,"given":"Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2020.06.007_bib1","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1039\/C5NP00121H","article-title":"The use of isolated natural products as scaffolds for the generation of chemically diverse screening libraries for drug discovery","volume":"33","author":"Barnes","year":"2016","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.apsb.2020.06.007_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2020.06.007_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2014","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2020.06.007_bib4","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.apsb.2019.05.004","article-title":"Structural simplification: an efficient strategy in lead optimization","volume":"9","author":"Wang","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2020.06.007_bib5","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.cell.2015.11.031","article-title":"A new golden age of natural products drug discovery","volume":"163","author":"Shen","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2020.06.007_bib6","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1021\/acs.jmedchem.6b00473","article-title":"Underexplored opportunities for natural products in drug discovery","volume":"59","author":"DeCorte","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib7","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.drudis.2008.07.004","article-title":"Natural products in drug discovery","volume":"13","author":"Harvey","year":"2008","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2020.06.007_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1168243","article-title":"Drug discovery and natural products: end of an era or an endless frontier?.","volume":"325","author":"Li","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.apsb.2020.06.007_bib9","first-page":"206","article-title":"Traditional Chinese medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP)","volume":"18","author":"Du","year":"2020","journal-title":"Chin J Nat Med"},{"key":"10.1016\/j.apsb.2020.06.007_bib10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1039\/c3np20097c","article-title":"Perspectives on natural product epigenetic modulators in chemical biology and medicine","volume":"30","author":"Cherblanc","year":"2013","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.apsb.2020.06.007_bib11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ja.2011.35","article-title":"Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma","volume":"64","author":"VanderMolen","year":"2011","journal-title":"J Antibiot"},{"key":"10.1016\/j.apsb.2020.06.007_bib12","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.cclet.2020.03.028","article-title":"New techniques and strategies in drug discovery","volume":"31","author":"Du","year":"2020","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2020.06.007_bib13","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","article-title":"Histone demethylation mediated by the nuclear amine oxidase homolog LSD1","volume":"119","author":"Shi","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2020.06.007_bib14","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.12688\/f1000research.12169.1","article-title":"LSD1, a double-edged sword, confers dynamic chromatin regulation but commonly promotes aberrant cell growth","volume":"6","author":"Kozub","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.apsb.2020.06.007_bib15","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.bbagrm.2013.05.002","article-title":"The histone LSD1 demethylase in stemness and cancer transcription programs","volume":"1829","author":"Amente","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2020.06.007_bib16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/cancers11030324","article-title":"Expanding the role of the histone lysine-specific demethylase LSD1 in cancer","volume":"11","author":"Majello","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.apsb.2020.06.007_bib17","doi-asserted-by":"crossref","first-page":"265ra169","DOI":"10.1126\/scitranslmed.3010643","article-title":"Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomes","volume":"6","author":"Hill","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2020.06.007_bib18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4155\/fmc-2018-0065","article-title":"Trends of LSD1 inhibitors in viral infections","volume":"10","author":"Zwergel","year":"2018","journal-title":"Future Med Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2018.05.052","article-title":"LSD1 Ablation stimulates anti-tumor immunity and enables checkpoint blockade","volume":"174","author":"Sheng","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2020.06.007_bib20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41388-018-0451-5","article-title":"Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade","volume":"38","author":"Qin","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2020.06.007_bib21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41590-018-0273-1","article-title":"Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis","volume":"20","author":"Hatzi","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2020.06.007_bib22","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1021\/acsmedchemlett.7b00426","article-title":"Lysine-specific demethylase 1 (LSD1) inhibitors as potential treatment for different types of cancers","volume":"8","author":"Abdel-Magid","year":"2017","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.apsb.2020.06.007_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.apsb.2018.10.006","article-title":"LSD1 inhibition suppresses the growth of clear cell renal cell carcinoma via upregulating P21 signaling","volume":"9","author":"Zhu","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2020.06.007_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12964-018-0275-5","article-title":"Pharmacological inhibition of LSD1 activity blocks REST-dependent medulloblastoma cell migration","volume":"16","author":"Callegari","year":"2018","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.apsb.2020.06.007_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13045-016-0252-7","article-title":"Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia","volume":"9","author":"Feng","year":"2016","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2020.06.007_bib26","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/j.exphem.2017.06.315","article-title":"Lsd1 inhibition induces differentiation and decreases leukemic stem cell frequency in Hoxa9\/Meis1-driven AML","volume":"53","author":"Barth","year":"2017","journal-title":"Exp Hematol"},{"key":"10.1016\/j.apsb.2020.06.007_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fonc.2018.00255","article-title":"Lysine-specific demethylase 1A as a promising target in acute myeloid leukemia","volume":"8","author":"Magliulo","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.apsb.2020.06.007_bib28","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.3390\/molecules23123194","article-title":"Pharmacological inhibition of LSD1 for cancer treatment","volume":"23","author":"Yang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2020.06.007_bib29","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1002\/1878-0261.12382","article-title":"Preclinical studies reveal that LSD1 inhibition results in tumor growth arrest in lung adenocarcinoma independently of driver mutations","volume":"12","author":"Macheleidt","year":"2018","journal-title":"Mol Oncol"},{"key":"10.1016\/j.apsb.2020.06.007_bib30","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2174\/156802661911190725094910","article-title":"Targeting histone lysine demethylase LSD1\/KDM1A as a new avenue for cancer therapy","volume":"19","author":"Fang","year":"2019","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib31","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/med.21334","article-title":"Reversible inhibitors of LSD1 as therapeutic agents in acute myeloid leukemia: clinical significance and progress to date","volume":"35","author":"Mould","year":"2015","journal-title":"Med Res Rev"},{"key":"10.1016\/j.apsb.2020.06.007_bib32","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/med.21350","article-title":"A systematic review of histone lysine-specific demethylase 1 and its inhibitors","volume":"35","author":"Zheng","year":"2015","journal-title":"Med Res Rev"},{"key":"10.1016\/j.apsb.2020.06.007_bib33","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.4155\/fmc-2017-0068","article-title":"Advances toward LSD1 inhibitors for cancer therapy","volume":"9","author":"Fu","year":"2017","journal-title":"Future Med Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/14728214.2019.1694001","article-title":"What potential is there for LSD1 inhibitors to reach approval for AML?.","volume":"24","author":"Pandey","year":"2019","journal-title":"Expet Opin Emerg Drugs"},{"key":"10.1016\/j.apsb.2020.06.007_bib35","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.2217\/epi.15.86","article-title":"Medicinal chemistry insights in the discovery of novel LSD1 inhibitors","volume":"7","author":"Wang","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.apsb.2020.06.007_bib36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-019-0811-9","article-title":"LSD1\/KDM1A inhibitors in clinical trials: advances and prospects","volume":"12","author":"Fang","year":"2019","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2020.06.007_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1601017","article-title":"Polymyxins and quinazolines are LSD1\/KDM1A inhibitors with unusual structural features","volume":"2","author":"Speranzini","year":"2016","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2020.06.007_bib38","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1158\/0008-5472.CAN-11-0896","article-title":"Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties","volume":"71","author":"Wang","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2020.06.007_bib39","doi-asserted-by":"crossref","first-page":"103648","DOI":"10.1016\/j.bioorg.2020.103648","article-title":"Natural protoberberine alkaloids, identified as potent selective LSD1 inhibitors, induce AML cell differentiation","volume":"97","author":"Li","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib40","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1038\/leu.2014.119","article-title":"Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells","volume":"28","author":"Fiskus","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.apsb.2020.06.007_bib41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nm.2661","article-title":"Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia","volume":"18","author":"Schenk","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2020.06.007_bib42","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1039\/c004698c","article-title":"The biological potential of flavones","volume":"27","author":"Verma","year":"2010","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.apsb.2020.06.007_bib43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejmech.2014.07.013","article-title":"Flavones: an important scaffold for medicinal chemistry","volume":"84","author":"Singh","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bioorg.2016.10.004","article-title":"Baicalin, a natural LSD1 inhibitor","volume":"69","author":"Zheng","year":"2016","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.aca.2018.01.014","article-title":"Bioactivity-guided cut countercurrent chromatography for isolation of lysine-specific demethylase 1 inhibitors from Scutellaria baicalensis Georgi","volume":"1016","author":"Han","year":"2018","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.apsb.2020.06.007_bib46","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bmc.2018.12.013","article-title":"Flavone-based natural product agents as new lysine-specific demethylase 1 inhibitors exhibiting cytotoxicity against breast cancer cells in\u00a0vitro","volume":"27","author":"Xu","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib47","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.4155\/fmc-2017-0086","article-title":"Dual\/multitargeted xanthone derivatives for Alzheimer's disease: where do we stand?.","volume":"9","author":"Cruz","year":"2017","journal-title":"Future Med Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201900499","article-title":"Xanthones and cancer: from natural sources to mechanisms of action","volume":"17","author":"Klein-J\u00fanior","year":"2020","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.apsb.2020.06.007_bib49","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.2174\/09298673113209990144","article-title":"Xanthones as potential antioxidants","volume":"20","author":"Panda","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib50","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3390\/molecules25030598","article-title":"Xanthones, a promising anti-inflammatory scaffold: structure, activity, and drug likeness analysis","volume":"25","author":"Feng","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2020.06.007_bib51","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/13543776.2018.1455829","article-title":"Bioactivity and pharmacological properties of \u03b1-mangostin from the mangosteen fruit: a review","volume":"28","author":"Chen","year":"2018","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.apsb.2020.06.007_bib52","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12986-016-0148-0","article-title":"Alpha-mangostin from mangosteen (Garcinia mangostana Linn.) pericarp extract reduces high fat-diet induced hepatic steatosis in rats by regulating mitochondria function and apoptosis","volume":"13","author":"Tsai","year":"2016","journal-title":"Nutr Metab"},{"key":"10.1016\/j.apsb.2020.06.007_bib53","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bioorg.2017.12.004","article-title":"Bioactivity evaluation of natural product \u03b1-mangostin as a novel xanthone-based lysine-specific demethylase 1 inhibitor to against tumor metastasis","volume":"76","author":"Han","year":"2018","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ddr.21525","article-title":"Stilbene derivatives as new perspective in antifungal medicinal chemistry","volume":"80","author":"De Filippis","year":"2019","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.apsb.2020.06.007_bib55","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.2174\/0929867323666160517121629","article-title":"The use of stilbene scaffold in medicinal chemistry and multi-target drug design","volume":"23","author":"Elisa","year":"2016","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib56","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/molecules25030605","article-title":"Aza- and azo-stilbenes: bio-isosteric analogs of resveratrol","volume":"25","author":"Lizard","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2020.06.007_bib57","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11030-017-9736-9","article-title":"Synthetic approaches toward stilbenes and their related structures","volume":"21","author":"Khan","year":"2017","journal-title":"Mol Divers"},{"key":"10.1016\/j.apsb.2020.06.007_bib58","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/jcb.23431","article-title":"Cellular and molecular effects of resveratrol in health and disease","volume":"113","author":"Yu","year":"2012","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.apsb.2020.06.007_bib59","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature01960","article-title":"Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan","volume":"425","author":"Howitz","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2020.06.007_bib60","first-page":"56","article-title":"Natural Polyphenols inhibit lysine-specific demethylase-1 in\u00a0vitro","volume":"1","author":"Abdulla","year":"2013","journal-title":"J Biochem Pharmacol Res"},{"key":"10.1016\/j.apsb.2020.06.007_bib61","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bbrc.2010.09.014","article-title":"Histone demethylase LSD1 is required to induce skeletal muscle differentiation by regulating myogenic factors","volume":"401","author":"Choi","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2020.06.007_bib62","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejmech.2016.11.035","article-title":"Discovery of resveratrol derivatives as novel LSD1 inhibitors: design, synthesis and their biological evaluation","volume":"126","author":"Duan","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib63","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1016\/j.bmc.2018.10.037","article-title":"Design, synthesis and in\u00a0vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy","volume":"26","author":"Duan","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib64","first-page":"1687","article-title":"Naturally occurring diarylheptanoids","volume":"5","author":"Lv","year":"2010","journal-title":"Nat Prod Commun"},{"key":"10.1016\/j.apsb.2020.06.007_bib65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jpba.2017.08.051","article-title":"Characterization of diarylheptanoids: an emerging class of bioactive natural products","volume":"147","author":"Alberti","year":"2018","journal-title":"J Pharmaceut Biomed Anal"},{"key":"10.1016\/j.apsb.2020.06.007_bib66","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13046-017-0566-5","article-title":"Curcumin: the spicy modulator of breast carcinogenesis","volume":"36","author":"Banik","year":"2017","journal-title":"J Exp Clin Canc Res"},{"key":"10.1016\/j.apsb.2020.06.007_bib67","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","article-title":"The essential medicinal chemistry of curcumin","volume":"60","author":"Nelson","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib68","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2174\/138945012804545632","article-title":"Chemopreventive and chemotherapeutic potential of curcumin in breast cancer","volume":"13","author":"Dona","year":"2012","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.apsb.2020.06.007_bib69","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1002\/cncr.25414","article-title":"Development of curcumin as an epigenetic agent","volume":"116","author":"Fu","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.apsb.2020.06.007_bib70","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fgene.2019.00514","article-title":"Curcumin as an alternative epigenetic modulator: mechanism of action and potential effects","volume":"10","author":"Hassan","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.apsb.2020.06.007_bib71","doi-asserted-by":"crossref","first-page":"126683","DOI":"10.1016\/j.bmcl.2019.126683","article-title":"Design, synthesis and biological evaluation of curcumin analogues as novel LSD1 inhibitors","volume":"29","author":"Wang","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2020.06.007_bib72","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/17425255.2019.1650914","article-title":"Is curcumin bioavailability a problem in humans: lessons from clinical trials","volume":"15","author":"Kunnumakkara","year":"2019","journal-title":"Expet Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.apsb.2020.06.007_bib73","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejmech.2018.12.016","article-title":"The therapeutic potential of curcumin: a review of clinical trials","volume":"163","author":"Salehi","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib74","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/jpi.12267","article-title":"Melatonin: an ancient molecule that makes oxygen metabolically tolerable","volume":"59","author":"Manchester","year":"2015","journal-title":"J Pineal Res"},{"key":"10.1016\/j.apsb.2020.06.007_bib75","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11010-019-03617-5","article-title":"Melatonin and its ubiquitous anticancer effects","volume":"462","author":"Bhattacharya","year":"2019","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.apsb.2020.06.007_bib76","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3390\/cancers11111712","article-title":"Potential of melatonin as adjuvant therapy of oral cancer in the era of epigenomics","volume":"11","author":"Capote-Moreno","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.apsb.2020.06.007_bib77","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/jpi.12227","article-title":"Melatonin as a treatment for gastrointestinal cancer: a review","volume":"58","author":"Xin","year":"2015","journal-title":"J Pineal Res"},{"key":"10.1016\/j.apsb.2020.06.007_bib78","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neulet.2013.01.050","article-title":"Melatonin induces histone hyperacetylation in the rat brain","volume":"541","author":"Niles","year":"2013","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.apsb.2020.06.007_bib79","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-079X.2008.00587.x","article-title":"Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells","volume":"45","author":"Sharma","year":"2008","journal-title":"J Pineal Res"},{"key":"10.1016\/j.apsb.2020.06.007_bib80","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/jpi.12226","article-title":"Melatonin induces apoptosis of colorectal cancer cells through HDAC4 nuclear import mediated by CaMKII inactivation","volume":"58","author":"Wei","year":"2015","journal-title":"J Pineal Res"},{"key":"10.1016\/j.apsb.2020.06.007_bib81","doi-asserted-by":"crossref","first-page":"33756","DOI":"10.18632\/oncotarget.16808","article-title":"Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2020.06.007_bib82","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbrc.2013.12.144","article-title":"Inhibition of lysine-specific demethylase 1 by the acyclic diterpenoid geranylgeranoic\u00a0acid\u00a0and its derivatives","volume":"444","author":"Sakane","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2020.06.007_bib83","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.3390\/nu11071656","article-title":"Extra virgin olive oil contains a phenolic inhibitor\u00a0of\u00a0the\u00a0histone demethylase LSD1\/KDM1A","volume":"11","author":"Cuy\u00e0s","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.apsb.2020.06.007_bib84","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1021\/bi200247b","article-title":"Histone demethylase LSD1 is a folate-binding protein","volume":"50","author":"Luka","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.apsb.2020.06.007_bib85","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/pro.2469","article-title":"Crystal structure of the histone lysine specific demethylase LSD1 complexed with tetrahydrofolate","volume":"23","author":"Luka","year":"2014","journal-title":"Protein Sci"},{"key":"10.1016\/j.apsb.2020.06.007_bib86","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.apsb.2019.01.001","article-title":"Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1\/KDM1A)","volume":"9","author":"Li","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2020.06.007_bib87","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ejmech.2019.02.039","article-title":"Synthesis, structure\u2212activity relationship studies and biological characterization of new [1,2,4]triazolo[1,5-a]pyrimidine-based LSD1\/KDM1A inhibitors","volume":"167","author":"Wang","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib88","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.ejmech.2016.10.021","article-title":"Design, synthesis and biological evaluation of [1,2,4] triazolo [1,5-a] pyrimidines as potent lysine specific demethylase 1 (LSD1\/KDM1A) inhibitors","volume":"125","author":"Wang","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib89","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ejmech.2019.01.075","article-title":"Experience-based discovery (EBD) of aryl hydrazines as new scaffolds for the development of LSD1\/KDM1A inhibitors","volume":"166","author":"Li","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2020.06.007_bib90","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bioorg.2018.11.018","article-title":"Identification of osimertinib (AZD9291) as a lysine specific demethylase 1 inhibitor","volume":"84","author":"Li","year":"2019","journal-title":"Bioorg Chem"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221138352030616X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221138352030616X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:46:21Z","timestamp":1761929181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221138352030616X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S221138352030616X"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2020.06.007","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural products as LSD1 inhibitors for cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2020.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}